Get started
Author

Alejandro Ballesteros

Long-Term Outcomes of First-Admission Psychosis: A Naturalistic 21-Year Follow-Up Study of Symptomatic, Functional and Personal Recovery and Their Baseline Predictors
2021 · Victor Peralta, Elena García de Jalón, et al. · Schizophrenia Bulletin · 68
PDF
Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?
2018 · Alejandro Ballesteros, Ana M. Sánchez-Torres, et al. · Psychological Medicine · 67
Utility of the MoCA for cognitive impairment screening in long-term psychosis patients
2019 · Gustavo J. Gil-Berrozpe, Ana M. Sánchez-Torres, et al. · Schizophrenia Research · 51
PDF
No evidence of exogenous origin for the abnormal glutathione redox state in schizophrenia
2013 · Alejandro Ballesteros, Pan Jiang, et al. · Schizophrenia Research · 36
Electrophysiological intermediate biomarkers for oxidative stress in schizophrenia
2013 · Alejandro Ballesteros, Ann Summerfelt, et al. · Clinical Neurophysiology · 33
Elevated noise power in gamma band related to negative symptoms and memory deficit in schizophrenia
2012 · Vanessa Suazo, Álvaro Díez, et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 30
PDF
Optimized voxel brain morphometry: association between brain volumes and the response to atypical antipsychotics
2010 · Vicente Molina, Carmen Martín, et al. · European Archives of Psychiatry and Clinical Neuroscience · 27
A clinical staging model of psychotic disorders based on a long-term follow-up of first-admission psychosis: A validation study
2023 · Victor Peralta, Elena García de Jalón, et al. · Psychiatry Research · 22
Neurocognitive correlates of the varied domains of outcomes at 20 year follow-up of first-episode psychosis
2022 · M.J. Cuesta, A.M. Sánchez-Torres, et al. · Psychiatry Research · 17
PDF
Cognitive, community functioning and clinical correlates of the Clinical Assessment Interview for Negative Symptoms (CAINS) in psychotic disorders
2020 · Manuel J. Cuesta, Ana M. Sánchez-Torres, et al. · European Archives of Psychiatry and Clinical Neuroscience · 16
PDF
The longitudinal effect of antipsychotic burden on psychosocial functioning in first-episode psychosis patients: the role of verbal memory
2020 · Alejandro Ballesteros, Ana M. Sánchez Torres, et al. · Psychological Medicine · 14
PDF
Relapse of first-episode schizophrenia patients and neurocognitive impairment: The role of dopaminergic and anticholinergic burden
2022 · Manuel J. Cuesta, Alejandro Ballesteros, et al. · Schizophrenia Research · 13
PDF
Neuromotor dysfunction as a major outcome domain of psychotic disorders: A 21-year follow-up study
2022 · Victor Peralta, Elena García de Jalón, et al. · Schizophrenia Research · 13
PDF
Voxel-based morphometry comparison between first episodes of psychosis with and without evolution to schizophrenia
2010 · Vicente Molina, Javier Sanz, et al. · Psychiatry Research Neuroimaging · 13
Interrelationships between polygenic risk scores, cognition, symptoms, and functioning in first-episode psychosis: A network analysis approach
2024 · Gustavo J. Gil-Berrozpe, Alex G. Segura, et al. · European Neuropsychopharmacology · 11
PDF
Prepulse inhibition of the startle reflex in schizophrenia remains stable with short-term quetiapine
2010 · V. Molina, D.E. López, et al. · European Psychiatry · 7
Social exclusion as a major outcome domain of psychotic disorders: early predictors, and associations with non-recovery and clinical staging 21 years after a first episode of psychosis
2024 · Victor Peralta, Elena García de Jalón, et al. · Social Psychiatry and Psychiatric Epidemiology · 6
SSRIs and QT interval prolongation management. A review
2017 · A. Ballesteros, H. Saiz, et al. · European Psychiatry · 5
PDF
Empirical validity of Leonhard's psychoses: A long-term follow-up study of first-episode psychosis patients
2023 · M.J. Cuesta, A.M. Sánchez-Torres, et al. · Schizophrenia Research · 4
PDF
Clinical case: Phelan–McDermid and pharmacological management
2017 · A. Ballesteros, Á.S. Rosero, et al. · European Psychiatry · 4
PDF
Can Polygenic Risk Scores for Metabolic Syndrome Contribute to Long-Term Syndrome Development in First-Episode Psychosis Patients? A Naturalistic 21-Year Follow-Up Study
2025 · Manuel J Cuesta, Sergi Papiol, et al. · Schizophrenia Bulletin · 2
The effectiveness of an add-on postbiotic to antipsychotic drugs for prevention of metabolic disturbances in patients with first-episode psychosis and schizophrenia spectrum disorder. A double blind clinical trial
2025 · J. Chato Noriega, E. Giné Servén, et al. · European Psychiatry · 2
PDF
Bioenergetic markers in cerebrospinal fluid in first-episode psychosis: Are they predictors of early antipsychotic response and 1-year outcomes?
2025 · Eloi Giné-Servén, Ester Boix-Quintana, et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2
Long-term trajectories of clinical staging in first-episode psychosis and their associated cognitive outcome: A 21-year follow-up study
2024 · Manuel J. Cuesta, Ana M. Sánchez-Torres, et al. · Revista de Psiquiatría y Salud Mental · 2
A neuropsychological study on Leonhard’s nosological system
2021 · Manuel J. Cuesta, Ana M. Sánchez-Torres, et al. · European Archives of Psychiatry and Clinical Neuroscience · 2
PDF
Works count: 37
Citation count: 470
H-index: 13
I10-index: 15
Year
Topic
Type